CMS Approves CureOne Registry to Collect MIPS-Related Metrics Around Cancer Molecular Testing

The US Centers for Medicare & Medicaid Services has approved CureOne’s N1 Registry as a repository to which doctors can submit data and show that they are meeting quality metrics around cancer biomarker testing tied to payment.

Source: https://www.genomeweb.com/molecular-diagnostics/cms-approves-cureone-registry-collect-mips-related-metrics-around-cancer?utm_source=Sailthru&utm_medium=email&utm_campaign=GW%20Cancer%20Thurs%202018-01-18&utm_term=Cancer%20Bulletin